HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Intra-abdominal vitelline remnant — Clinical Guidelines

Overview

Intra-abdominal vitelline remnants, often associated with complications like intra-abdominal sepsis, involve remnants of embryonic structures that can harbor infection and contribute to severe clinical outcomes including systemic inflammatory response and organ failure 1 3 6 7.

Diagnosis

Clinical signs include localized tenderness, fever, absent bowel sounds, and systemic inflammatory response indicators 8.

Imaging studies such as CAT scans and contrast radiographs are commonly used, with reported accuracy rates of 76% and 81% respectively 8.

Positive peritoneal signs identified via imaging (CAT/ultrasound) or clinical examination guide directed relaparotomies 7.

Management

First-line treatments: Early surgical intervention for source control, including drainage of abscesses and correction of technical errors 6 8.

Antibiotics: Amikacin dosing tailored to pharmacokinetic parameters to correlate with organ dysfunction biomarkers like ESR and drug clearance 2.

Negative Pressure Peritoneal Therapy (NPPT): Considered as adjunctive therapy to reduce systemic inflammatory response post-damage control laparotomy 3.

Relaparotomy: Indicated based on clinical and radiographic findings, with directed relaparotomies showing higher success rates compared to non-directed procedures 7.

Special Populations

Elderly: Increased risk of mortality associated with age >65 years, shock, alcoholism, and malnutrition 9.

Jaundiced patients: Higher mortality rates noted, often due to complex intra-abdominal abscesses and multiple organ failure 6.

Key Recommendations

Perform directed relaparotomies based on positive peritoneal signs or imaging findings to identify and address the source of sepsis (Evidence: Strong 7).

Utilize negative pressure therapy in open abdomen management to potentially reduce systemic inflammatory response, though risks must be weighed (Evidence: Moderate 3).

Tailor antibiotic therapy, such as amikacin dosing, to individual pharmacokinetic profiles to correlate with inflammatory biomarkers (Evidence: Weak 2).

Consider early relaparotomy in patients with clinical signs of ongoing sepsis despite initial management, guided by predictive indices to optimize outcomes (Evidence: Moderate 4).

Closely monitor elderly patients and those with comorbidities like jaundice for higher risk of mortality and complications (Evidence: Moderate 6 9).

References

1 Kirkpatrick AW, Coccolini F, Tolonen M, Minor S, Catena F, Gois E et al.. The unrestricted global effort to complete the COOL trial. World journal of emergency surgery : WJES 2023. link 2 Shahrami B, Sefidani Forough A, Khezrnia SS, Najmeddin F, Arabzadeh AA, Rouini MR et al.. Relationship between amikacin pharmacokinetics and biological parameters associated with organ dysfunction: a case series study of critically ill patients with intra-abdominal sepsis. European journal of hospital pharmacy : science and practice 2022. link 3 Roberts DJ, Jenne CN, Ball CG, Tiruta C, Léger C, Xiao Z et al.. Efficacy and safety of active negative pressure peritoneal therapy for reducing the systemic inflammatory response after damage control laparotomy (the Intra-peritoneal Vacuum Trial): study protocol for a randomized controlled trial. Trials 2013. link 4 Pusajó JF, Bumaschny E, Doglio GR, Cherjovsky MR, Lipinszki AI, Hernández MS et al.. Postoperative intra-abdominal sepsis requiring reoperation. Value of a predictive index. Archives of surgery (Chicago, Ill. : 1960) 1993. link 5 Sessions SC, vonRueden DG, Uribe A. Diagnostic laparoscopy. Journal of laparoendoscopic surgery 1991. link 6 Mäkelä J, Kairaluoma MI. Relaparotomy for postoperative intra-abdominal sepsis in jaundiced patients. The British journal of surgery 1988. link 7 Bunt TJ. Non-directed relaparotomy for intra-abdominal sepsis. A futile procedure. The American surgeon 1986. link 8 Hinsdale JG, Jaffe BM. Re-operation for intra-abdominal sepsis. Indications and results in modern critical care setting. Annals of surgery 1984. link 9 Pine RW, Wertz MJ, Lennard ES, Dellinger EP, Carrico CJ, Minshew BH. Determinants of organ malfunction or death in patients with intra-abdominal sepsis. A discriminant analysis. Archives of surgery (Chicago, Ill. : 1960) 1983. link 10 Jones J, Gough D. Coeliac plexus block with alcohol for relief of upper abdominal pain due to cancer. Annals of the Royal College of Surgeons of England 1977. link

Intra-abdominal vitelline remnant